欧洲生物分析测试服务市场预测至 2030 年 - 区域分析 - 按服务(药代动力学、生物标志物、免疫原性、病毒学测试、细胞分析等);疾病适应症(心血管、神经系统疾病、代谢紊乱、自身免疫性疾病、呼吸系统疾病、肿瘤、性健康、骨病等);最终用户 [制药和生物制药公司、合同研究组织 (CRO)、合同开发和制造组织 (CDMO) 等]

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 117    |    Report Code: BMIRE00029558    |    Category: Life Sciences

Europe Bioanalytical Testing Services Market

2022年欧洲生物分析测试服务市场价值为13.7448亿美元,预计到2030年将达到29.5696亿美元;预计 2022 年至 2030 年复合年增长率为 10.0%。



对生物仿制药和生物制剂分析测试的高需求推动了欧洲生物分析测试服务市场

生物制剂是是医药市场上最有前途的重要治疗领域之一。炎症性肠病、癌症和类风湿性关节炎等慢性病病例数量的增加推动了对生物制剂的需求。然而,近年来,生物制剂的高成本已将药物开发商和医疗保健利益相关者的注意力转向生物仿制药。此外,生物制剂专利和独占期即将到期也为生物仿制药的开发创造了机会。据麦肯锡公司称,到 2025 年,约有 19 种大批量生物制剂将失去排他性。此外,预计在 2026 年至 2032 年间,还有 39 种大容量生物制剂将失去专利保护,更多生物制剂可能会紧随其后。无障碍药物协会 (AAM) 预计,生物仿制药推出后,品牌生物制剂的平均价格将下降 25% 左右,因为生物仿制药的平均销售价格比原品牌生物制剂低 50% 左右。

生物仿制药研发的预期增长将增加对相关生物分析测试服务的需求——生物仿制药的兼容性研究、稳定性测试、产品发布测试和生物仿制药蛋白质分析——以降低药物开发所涉及的风险。因此,生物仿制药分析测试需求的增长正在推动生物分析测试服务市场的增长。

欧洲生物分析测试服务市场概述

欧洲生物分析测试服务市场细分为德国、英国、法国、意大利、西班牙和欧洲其他国家。该地区在全球生物分析测试服务市场中占据重要地位。由于制药、生物制药和生物技术行业强大的制造能力,以及欧洲不同国家领先的生物分析测试服务提供商的存在,预计欧洲生物分析测试服务市场在预测期内将出现显着增长。
< br>欧洲生物分析测试服务市场收入和预测到 2030 年(百万美元)

欧洲生物分析测试服务市场细分

欧洲生物分析测试服务市场根据测试类型、疾病适应症进行细分、最终用户和国家/地区。

根据测试类型,欧洲生物分析测试服务市场分为药代动力学、生物标志物、免疫原性、病毒学测试、基于细胞的测定等。基于细胞的检测领域在 2022 年占据最大的市场份额。

根据疾病指示,欧洲生物分析测试服务市场分为心血管、神经系统疾病、代谢疾病、呼吸系统疾病、自身免疫性疾病、肿瘤、性健康、骨骼疾病等。肿瘤学领域在 2022 年占据最大的市场份额。

根据最终用户,欧洲生物分析测试服务市场分为制药和生物制药公司、合同研究组织 (CRO)、合同开发和制造组织 (CDMO) ), 和别的。制药和生物制药公司细分市场在 2022 年占据最大的市场份额。

根据国家/地区,欧洲生物分析测试服务市场分为德国、英国、法国、意大利、西班牙和欧洲其他地区。德国在 2022 年占据欧洲生物分析测试服务市场份额。

SGS SA、康龙化成北京有限公司、Element Materials Technology Group Ltd、Charles River Laboratories International Inc、Eurofins Scientific SE、Labcorp Drug Development Inc、Syneos Health Inc 、KCAS Bioanalytical and Biomarker Services LLC、ICON Plc 和 Intertek Group Plc 是欧洲生物分析测试服务市场上的一些领先公司。



Europe Bioanalytical Testing Services Strategic Insights

Strategic insights for Europe Bioanalytical Testing Services involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-bioanalytical-testing-services-market-strategic-framework.webp
Get more information on this report

Europe Bioanalytical Testing Services Report Scope

Report Attribute Details
Market size in 2022 US$ 1,374.48 Million
Market Size by 2030 US$ 2,956.96 Million
Global CAGR (2022 - 2030) 10.0%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 服务
  • 药代动力学
  • 生物标志物
  • 免疫原性
  • 病毒学测试
  • 基于细胞的分析
By 疾病适应症
  • 心血管疾病
  • 神经系统疾病
  • 代谢性疾病
  • 自身免疫性疾病
  • 呼吸系统疾病
  • 肿瘤学
  • 性健康
  • 骨病
By 最终用户
  • 制药和生物制药公司
  • 合同研究组织
  • 合同开发和制造组织
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • SGS SA
  • Pharmaron Beijing Co Ltd
  • Element Materials Technology Group Ltd
  • Charles River Laboratories International Inc
  • Eurofins Scientific SE
  • Labcorp Drug Development Inc
  • Syneos Health Inc
  • KCAS Bioanalytical and Biomarker Services LLC
  • ICON Plc
  • Intertek Group Plc
  • Get more information on this report

    Europe Bioanalytical Testing Services Regional Insights

    The regional scope of Europe Bioanalytical Testing Services refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-bioanalytical-testing-services-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Bioanalytical Testing Services Market

    1. SGS SA

    2. Pharmaron Beijing Co Ltd

    3. Element Materials Technology Group Ltd

    4. Charles River Laboratories International Inc

    5. Eurofins Scientific SE

    6. Labcorp Drug Development Inc

    7. Syneos Health Inc

    8. KCAS Bioanalytical and Biomarker Services LLC

    9. ICON Plc

    10. Intertek Group Plc

    Frequently Asked Questions
    How big is the Europe Bioanalytical Testing Services Market?

    The Europe Bioanalytical Testing Services Market is valued at US$ 1,374.48 Million in 2022, it is projected to reach US$ 2,956.96 Million by 2030.

    What is the CAGR for Europe Bioanalytical Testing Services Market by (2022 - 2030)?

    As per our report Europe Bioanalytical Testing Services Market, the market size is valued at US$ 1,374.48 Million in 2022, projecting it to reach US$ 2,956.96 Million by 2030. This translates to a CAGR of approximately 10.0% during the forecast period.

    What segments are covered in this report?

    The Europe Bioanalytical Testing Services Market report typically cover these key segments-

  • 服务 (药代动力学, 生物标志物, 免疫原性, 病毒学测试, 基于细胞的分析)
  • 疾病适应症 (心血管疾病, 神经系统疾病, 代谢性疾病, 自身免疫性疾病, 呼吸系统疾病, 肿瘤学, 性健康, 骨病)
  • 最终用户 (制药和生物制药公司, 合同研究组织, 合同开发和制造组织)
  • What is the historic period, base year, and forecast period taken for Europe Bioanalytical Testing Services Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Bioanalytical Testing Services Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Europe Bioanalytical Testing Services Market?

    The Europe Bioanalytical Testing Services Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • SGS SA
  • Pharmaron Beijing Co Ltd
  • Element Materials Technology Group Ltd
  • Charles River Laboratories International Inc
  • Eurofins Scientific SE
  • Labcorp Drug Development Inc
  • Syneos Health Inc
  • KCAS Bioanalytical and Biomarker Services LLC
  • ICON Plc
  • Intertek Group Plc
  • Who should buy this report?

    The Europe Bioanalytical Testing Services Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Bioanalytical Testing Services Market value chain can benefit from the information contained in a comprehensive market report.